Fig. 6. Increased ERK activation in the vasculature of GNAQQ209L expressing mice and patient vascular tumor.
a Tamoxifen induction scheme for analysis of subcutaneous tissue. b Representative images of subcutaneous tissue of tamoxifen-treated control and iCdh5-GNAQQ209L mutant mice stained for ERG (white), pERK (red), Ki67 (green), and merge. Scale bar: 50 μm. c ERG staining marks EC nuclei. Quantification of ERG+ cells normalized per subcutaneous tissue area. pERK+ and Ki67+ and double-positive endothelial cells were normalized to total EC number. iCdh5-GNAQQ209L (n = 9) and control littermates (n = 9), mean±SD, unpaired two-tailed Welch’s t-test. Mouse genotypes are indicated. d GNAQQ209L mutant patient-derived vascular tumor tissue was analyzed. e Representative images of neonatal human foreskin and patient-derived tissue (cutaneous vascular tumor) with somatic GNAQ p.Q209L mutation immuo-stained for UEAI (Ulex europaeus agglutinin-I) (brown). Scale bar: 50μm. f Representative images of neonatal human foreskin and patient-derived tissue with somatic GNAQ p.Q209L mutation labeled for UEAI (white), pERK (red), Ki67 (green), and merge with DAPI (blue). Scale bar: 50 μm. g Quantification of the UEAI+ vascular area as percentage of total field area, pERK+, Ki67+ and double-positive EC calculated as events per mm2 of vascular area; human foreskin tissue from n = 5 different donors, and n = 1 patient-derived tumor tissue, mean±SD. Source data for (c,g) are provided as a Source Data file. Schematic in (a,d) created with Biorender.com.
